Published in Nucleic Acids Res on December 01, 2002
Genome-wide search for novel human uORFs and N-terminal protein extensions using ribosomal footprinting. Genome Res (2012) 1.73
A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression. Hum Mol Genet (2011) 1.39
Expression of the Alzheimer protease BACE1 is suppressed via its 5'-untranslated region. EMBO Rep (2004) 1.27
Begin at the beginning: predicting genes with 5' UTRs. Genome Res (2005) 1.14
Translational regulation of BACE-1 expression in neuronal and non-neuronal cells. Nucleic Acids Res (2004) 1.05
Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region. J Biol Chem (2010) 0.94
Functional characterization of two novel 5' untranslated exons reveals a complex regulation of NOD2 protein expression. BMC Genomics (2007) 0.93
Huntingtin gene evolution in Chordata and its peculiar features in the ascidian Ciona genus. BMC Genomics (2006) 0.85
Multiple mechanisms influence regulation of the cystic fibrosis transmembrane conductance regulator gene promoter. Am J Respir Cell Mol Biol (2009) 0.83
Thousands of novel translated open reading frames in humans inferred by ribosome footprint profiling. Elife (2016) 0.83
Complex regulation of human cathelicidin gene expression: novel splice variants and 5'UTR negative regulatory element. Mol Immunol (2007) 0.83
Role of context in RNA structure: flanking sequences reconfigure CAG motif folding in huntingtin exon 1 transcripts. Biochemistry (2013) 0.82
The A2A adenosine receptor is a dual coding gene: a novel mechanism of gene usage and signal transduction. J Biol Chem (2013) 0.76
CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease. Int J Mol Sci (2017) 0.75
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res (1987) 36.83
CpG islands in vertebrate genomes. J Mol Biol (1987) 23.16
Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature (1988) 19.07
Possible role of flanking nucleotides in recognition of the AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Res (1981) 18.27
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell (1996) 12.59
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science (1997) 11.53
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57
Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature (1994) 9.30
Insertion mutagenesis to increase secondary structure within the 5' noncoding region of a eukaryotic mRNA reduces translational efficiency. Cell (1985) 7.95
Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes. Mol Cell Biol (1987) 6.67
Translational regulation of yeast GCN4. A window on factors that control initiator-trna binding to the ribosome. J Biol Chem (1997) 5.37
Upstream open reading frames as regulators of mRNA translation. Mol Cell Biol (2000) 4.99
Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet (1995) 3.72
Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell (1995) 3.45
Inactivation of the mouse Huntington's disease gene homolog Hdh. Science (1995) 2.96
Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet (1996) 2.88
Complete translation of encephalomyocarditis virus RNA and faithful cleavage of virus-specific proteins in a cell-free system from Krebs-2 cells. FEBS Lett (1978) 2.75
Posttranscriptional control of gene expression in yeast. Microbiol Mol Biol Rev (1998) 2.54
Activation of a cellular oncogene by DNA rearrangement: possible involvement of an IS-like element. Nature (1982) 2.45
Translational activation of the lck proto-oncogene. Nature (1988) 2.41
Ribosome regulation by the nascent peptide. Microbiol Rev (1996) 2.41
Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet (1995) 2.33
Physical evidence for distinct mechanisms of translational control by upstream open reading frames. EMBO J (2001) 2.02
Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet (1993) 1.67
Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci U S A (1995) 1.50
Evolutionarily conserved features of the arginine attenuator peptide provide the necessary requirements for its function in translational regulation. J Biol Chem (2000) 1.33
Arginine-specific regulation mediated by the Neurospora crassa arg-2 upstream open reading frame in a homologous, cell-free in vitro translation system. J Biol Chem (1997) 1.27
Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J Neurosci (1997) 1.05
Polymorphism analysis of the huntingtin gene in Italian families affected with Huntington disease. Hum Mol Genet (1994) 1.01
Functional analysis of the Huntington's disease (HD) gene promoter. Hum Mol Genet (1998) 0.96
Termination and peptide release at the upstream open reading frame are required for downstream translation on synthetic shunt-competent mRNA leaders. Mol Cell Biol (2000) 0.95
Huntington disease: new insights into the relationship between CAG expansion and disease. Hum Mol Genet (1996) 0.94
Forced engagement of a RNA/protein complex by a chemical inducer of dimerization to modulate gene expression. Proc Natl Acad Sci U S A (2002) 0.91
Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum Mol Genet (1995) 0.89
Elements in the murine c-mos messenger RNA 5'-untranslated region repress translation of downstream coding sequences. Cell Growth Differ (1996) 0.88
Expression of the Huntington disease gene in rodents: cloning the rat homologue and evidence for downregulation in non-neuronal tissues during development. Hum Mol Genet (1995) 0.85
Structural analysis of the 5' region of mouse and human Huntington disease genes reveals conservation of putative promoter region and di- and trinucleotide polymorphisms. Genomics (1995) 0.83
Functional characterization of the human Huntington's disease gene promoter. Brain Res Mol Brain Res (2001) 0.81
Isolation and characterization of the rat huntingtin promoter. Biochem J (1998) 0.79
Analysis of the 5' upstream sequence of the Huntington's disease (HD) gene shows six new rare alleles which are unrelated to the age at onset of HD. J Med Genet (1997) 0.77
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature (2004) 8.76
Short RNAs repress translation after initiation in mammalian cells. Mol Cell (2006) 6.70
Statistical practice in high-throughput screening data analysis. Nat Biotechnol (2006) 5.85
Antimicrobial drug discovery through bacteriophage genomics. Nat Biotechnol (2004) 4.17
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat Chem Biol (2006) 3.89
The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc Natl Acad Sci U S A (2005) 3.84
Dissecting eIF4E action in tumorigenesis. Genes Dev (2007) 3.53
eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell (2007) 3.46
Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2alpha phosphorylation. Mol Biol Cell (2006) 2.84
mTORC1 promotes survival through translational control of Mcl-1. Proc Natl Acad Sci U S A (2008) 2.50
Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest (2008) 2.40
Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci U S A (2009) 2.40
Comparative genomic analysis of 18 Pseudomonas aeruginosa bacteriophages. J Bacteriol (2006) 2.18
Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol. PLoS One (2009) 2.11
Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation. Proc Natl Acad Sci U S A (2005) 2.00
Structural conservation of druggable hot spots in protein-protein interfaces. Proc Natl Acad Sci U S A (2011) 1.95
A tumour suppressor network relying on the polyamine-hypusine axis. Nature (2012) 1.85
RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation. Chem Biol (2006) 1.71
Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs. RNA (2008) 1.69
Altering chemosensitivity by modulating translation elongation. PLoS One (2009) 1.68
Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proc Natl Acad Sci U S A (2005) 1.65
Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. Nucleic Acids Res (2004) 1.62
High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay. J Biomol Screen (2005) 1.61
Tumorigenic activity and therapeutic inhibition of Rheb GTPase. Genes Dev (2008) 1.60
Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Cancer Res (2006) 1.60
Caliciviruses differ in their functional requirements for eIF4F components. J Biol Chem (2006) 1.60
Initiation of protein synthesis by hepatitis C virus is refractory to reduced eIF2.GTP.Met-tRNA(i)(Met) ternary complex availability. Mol Biol Cell (2006) 1.51
Uncoupling stress granule assembly and translation initiation inhibition. Mol Biol Cell (2009) 1.49
Selective pharmacological targeting of a DEAD box RNA helicase. PLoS One (2008) 1.49
Migrating pharyngeal foreign bodies: a series of four cases of saw-toothed fish bones. Eur Arch Otorhinolaryngol (2008) 1.48
Problems with co-funding in Canada. Science (2005) 1.48
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma. J Exp Med (2011) 1.45
Repurposing CRISPR/Cas9 for in situ functional assays. Genes Dev (2013) 1.41
Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Angew Chem Int Ed Engl (2007) 1.40
c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Cancer Res (2008) 1.40
Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases. Cancer Res (2011) 1.35
A novel function of eIF2alpha kinases as inducers of the phosphoinositide-3 kinase signaling pathway. Mol Biol Cell (2007) 1.32
Mitochondrion-dependent N-terminal processing of outer membrane Mcl-1 protein removes an essential Mule/Lasu1 protein-binding site. J Biol Chem (2011) 1.31
Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F. Proc Natl Acad Sci U S A (2010) 1.30
Inhibition of translation by RNA-small molecule interactions. RNA (2002) 1.27
A new class of small molecule RNA polymerase inhibitors with activity against rifampicin-resistant Staphylococcus aureus. Bioorg Med Chem (2006) 1.23
Translation of nonSTOP mRNA is repressed post-initiation in mammalian cells. EMBO J (2007) 1.20
Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles. RNA (2004) 1.15
A cellular response linking eIF4AI activity to eIF4AII transcription. RNA (2012) 1.13
Evidence for a functionally relevant rocaglamide binding site on the eIF4A-RNA complex. ACS Chem Biol (2013) 1.12
Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis. Cell Rep (2012) 1.12
Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. FASEB J (2010) 1.10
Targeting translation dependence in cancer. Oncotarget (2011) 1.09
Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells. Leuk Res (2009) 1.09
c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy. Cancer Res (2009) 1.08
The herpes simplex virus 1 vhs protein enhances translation of viral true late mRNAs and virus production in a cell type-dependent manner. J Virol (2011) 1.08
Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor. Nat Genet (2005) 1.05
The translation inhibitor pateamine A prevents cachexia-induced muscle wasting in mice. Nat Commun (2012) 1.05
Biomimetic photocycloaddition of 3-hydroxyflavones: synthesis and evaluation of rocaglate derivatives as inhibitors of eukaryotic translation. Angew Chem Int Ed Engl (2010) 1.05
Emerging therapeutics targeting mRNA translation. Cold Spring Harb Perspect Biol (2012) 1.04
Synergistic effects between analogs of DNA and RNA improve the potency of siRNA-mediated gene silencing. Nucleic Acids Res (2010) 1.03
2'-fluoro-4'-thioarabino-modified oligonucleotides: conformational switches linked to siRNA activity. Nucleic Acids Res (2007) 1.03
Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies. J Med Chem (2011) 1.03
Inhibitors of translation initiation as cancer therapeutics. Future Med Chem (2009) 1.02
Internal translation initiation mediated by the angiogenic factor Tie2. J Biol Chem (2005) 1.01
WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2. Oncogene (2003) 1.01
Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett (2002) 1.00
Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer. Am J Clin Pathol (2008) 1.00
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a novel RNA-binding protein that inhibits protein synthesis. J Neurosci Res (2009) 0.99
Hepatitis C virus-related internal ribosome entry sites are found in multiple genera of the family Picornaviridae. J Gen Virol (2006) 0.99
A modular and flexible ESC-based mouse model of pancreatic cancer. Genes Dev (2014) 0.99
Cap-dependent eukaryotic initiation factor-mRNA interactions probed by cross-linking. RNA (2008) 0.96
Inhibitors of translation targeting eukaryotic translation initiation factor 4A. Methods Enzymol (2012) 0.95
Characterization of hMTr1, a human Cap1 2'-O-ribose methyltransferase. J Biol Chem (2010) 0.94
Translation initiation: a critical signalling node in cancer. Expert Opin Ther Targets (2009) 0.94
RNAi screening uncovers Dhx9 as a modifier of ABT-737 resistance in an Eμ-myc/Bcl-2 mouse model. Blood (2013) 0.93
The eukaryotic initiation factor eIF4H facilitates loop-binding, repetitive RNA unwinding by the eIF4A DEAD-box helicase. Nucleic Acids Res (2012) 0.92
The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling. Cancer Res (2010) 0.92
A new antimalarial quassinoid from Simaba orinocensis. J Nat Prod (2004) 0.92
her-2 upstream open reading frame effects on the use of downstream initiation codons. Biochem Biophys Res Commun (2006) 0.92
The yeast split-ubiquitin membrane protein two-hybrid screen identifies BAP31 as a regulator of the turnover of endoplasmic reticulum-associated protein tyrosine phosphatase-like B. Mol Cell Biol (2004) 0.92
Nucleotide binding and nucleotide hydrolysis properties of the ABC transporter MRP6 (ABCC6). Biochemistry (2002) 0.91
PAX2 activates WNT4 expression during mammalian kidney development. J Biol Chem (2005) 0.91
Insights into the physiological role of WT1 from studies of genetically modified mice. Physiol Genomics (2004) 0.91
Persistent transcription- and translation-dependent long-term potentiation induced by mGluR1 in hippocampal interneurons. J Neurosci (2009) 0.91
Blocking eIF4E-eIF4G interaction as a strategy to impair coronavirus replication. J Virol (2011) 0.91
Forced engagement of a RNA/protein complex by a chemical inducer of dimerization to modulate gene expression. Proc Natl Acad Sci U S A (2002) 0.91
Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition. J Nat Prod (2009) 0.90
Multidrug resistance is common in Escherichia coli associated with ileal Crohn's disease. Inflamm Bowel Dis (2013) 0.90
Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap. RNA (2005) 0.90
Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic Biol Med (2006) 0.90
Two distinct groups of porcine enteropathogenic Escherichia coli strains of serogroup O45 are revealed by comparative genomic hybridization and virulence gene microarray. BMC Genomics (2009) 0.89
Triaminotriazine DNA helicase inhibitors with antibacterial activity. Bioorg Med Chem Lett (2005) 0.89
Cycloheximide and congeners as inhibitors of eukaryotic protein synthesis from endophytic actinomycetes Streptomyces sps. YIM56132 and YIM56141. J Antibiot (Tokyo) (2010) 0.89
Microarray-based detection of extended virulence and antimicrobial resistance gene profiles in phylogroup B2 Escherichia coli of human, meat and animal origin. J Med Microbiol (2011) 0.89
Silibinin inhibits translation initiation: implications for anticancer therapy. Mol Cancer Ther (2009) 0.89
Tumor progression and metastasis: role of translational deregulation. Anticancer Res (2012) 0.88
Phenylpyrrolocytosine as an unobtrusive base modification for monitoring activity and cellular trafficking of siRNA. ACS Chem Biol (2011) 0.88
Activation of the WT1 tumor suppressor gene promoter by Pea3. FEBS Lett (2004) 0.88
Eukaryotic initiation factor 4F: a vulnerability of tumor cells. Future Med Chem (2012) 0.88
Presence of multi-drug resistant pathogenic Escherichia coli in the San Pedro River located in the State of Aguascalientes, Mexico. Front Microbiol (2013) 0.87